Clinical Trial Update: Rh-endostatin in Combination With Dacarbazine and Cisplatin as the First Line Therapy for Metastatic Melanoma [Phase 2]

View source ↗

Summary

A Phase 2 trial investigates rh-endostatin in combination with dacarbazine and cisplatin as first-line therapy for metastatic melanoma. The current status of th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• CISPLATIN (cisplatin)
• Dacarbazine (dacarbazine)
• Endostar (recombinant human endostatin)

Snippet

Sponsor: Peking University Cancer Hospital & Institute | Conditions: Melanoma | Phase 2 | Status: UNKNOWN